318 related articles for article (PubMed ID: 27861826)
21. Decision-making deficit in chronic migraine patients with medication overuse.
Biagianti B; Grazzi L; Gambini O; Usai S; Muffatti R; Scarone S; Bussone G
Neurol Sci; 2012 May; 33 Suppl 1():S151-5. PubMed ID: 22644192
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study.
Yu S; Zhou J; Luo G; Xiao Z; Ettrup A; Jansson G; Florea I; Ranc K; Pozo-Rosich P
BMC Neurol; 2023 Dec; 23(1):441. PubMed ID: 38102535
[TBL] [Abstract][Full Text] [Related]
23. Predictors of successful primary care detoxification treatment for medication-overuse headache.
Kristoffersen ES; Straand J; Benth JŠ; Russell MB; Lundqvist C
Acta Neurol Scand; 2017 Nov; 136(5):486-494. PubMed ID: 28369734
[TBL] [Abstract][Full Text] [Related]
24. Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache.
Trucco M; Meineri P; Ruiz L;
J Headache Pain; 2005 Sep; 6(4):334-7. PubMed ID: 16362704
[TBL] [Abstract][Full Text] [Related]
25. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics of medication-overuse headache according to the class of acute medication: A cross-sectional multicenter study.
Oh SY; Kang JJ; Park HK; Cho SJ; Hong Y; Moon HS; Lee MJ; Song TJ; Im YJ; Son WJ; Roh YH; Chu MK
Headache; 2022 Jul; 62(7):890-902. PubMed ID: 35833500
[TBL] [Abstract][Full Text] [Related]
27. [Clinical features and mechanisms of chronic migraine and medication-overuse headache].
Takeshima T
Rinsho Shinkeigaku; 2010 Nov; 50(11):990-3. PubMed ID: 21921539
[TBL] [Abstract][Full Text] [Related]
28. The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review.
Deighton AM; Harris LA; Johnston K; Hogan S; Quaranta LA; L'Italien G; Coric V
BMC Neurol; 2021 Nov; 21(1):425. PubMed ID: 34727873
[TBL] [Abstract][Full Text] [Related]
29. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study.
Rossi P; Faroni JV; Nappi G
Cephalalgia; 2008 Nov; 28(11):1196-200. PubMed ID: 18727648
[TBL] [Abstract][Full Text] [Related]
30. Chronic migraine: current concepts and ongoing treatments.
Negro A; Rocchietti-March M; Fiorillo M; Martelletti P
Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1401-20. PubMed ID: 22288302
[TBL] [Abstract][Full Text] [Related]
31. A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.
Negro A; Curto M; Lionetto L; Martelletti P
J Headache Pain; 2015; 17():1. PubMed ID: 26792662
[TBL] [Abstract][Full Text] [Related]
32. The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort.
Schwedt TJ; Digre K; Tepper SJ; Spare NM; Ailani J; Birlea M; Burish M; Mechtler L; Gottschalk C; Quinn AM; McGillicuddy L; Bance L; Dumkrieger G; Chong CD; Dodick DW
Headache; 2020 Feb; 60(2):337-347. PubMed ID: 31755111
[TBL] [Abstract][Full Text] [Related]
33. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria.
Radat F; Creac'h C; Guegan-Massardier E; Mick G; Guy N; Fabre N; Giraud P; Nachit-Ouinekh F; Lantéri-Minet M
Headache; 2008 Jul; 48(7):1026-36. PubMed ID: 18081820
[TBL] [Abstract][Full Text] [Related]
34. Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial.
Pijpers JA; Kies DA; Louter MA; van Zwet EW; Ferrari MD; Terwindt GM
Brain; 2019 May; 142(5):1203-1214. PubMed ID: 30982843
[TBL] [Abstract][Full Text] [Related]
35. Medication-overuse headache: risk factors, pathophysiology and management.
Diener HC; Holle D; Solbach K; Gaul C
Nat Rev Neurol; 2016 Oct; 12(10):575-83. PubMed ID: 27615418
[TBL] [Abstract][Full Text] [Related]
36. Prednisone as initial treatment of analgesic-induced daily headache.
Krymchantowski AV; Barbosa JS
Cephalalgia; 2000 Mar; 20(2):107-13. PubMed ID: 10961766
[TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
38. Treatment of medication overuse headache: Effect and predictors after 1 year-A randomized controlled trial.
Carlsen LN; Rouw C; Westergaard ML; Nielsen M; Munksgaard SB; Bendtsen L; Jensen RH
Headache; 2021 Jul; 61(7):1112-1122. PubMed ID: 34325483
[TBL] [Abstract][Full Text] [Related]
39. Probable medication-overuse headache: the effect of a 2-month drug-free period.
Zeeberg P; Olesen J; Jensen R
Neurology; 2006 Jun; 66(12):1894-8. PubMed ID: 16707727
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and overuse patterns of medication overuse headache: Retrospective case-series study.
Kluonaitis K; Petrauskiene E; Ryliskiene K
Clin Neurol Neurosurg; 2017 Dec; 163():124-127. PubMed ID: 29101861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
